Warfarin overdose successfully treated using prophylactic vitamin K infusion without severe coagulopathy: A case report

IF 1.5 Q2 MEDICINE, GENERAL & INTERNAL
Ryosuke Omoto, Yutaka Umemura, Yuki Kokubu, Takeyuki Kiguchi, Satoshi Fujimi
{"title":"Warfarin overdose successfully treated using prophylactic vitamin K infusion without severe coagulopathy: A case report","authors":"Ryosuke Omoto,&nbsp;Yutaka Umemura,&nbsp;Yuki Kokubu,&nbsp;Takeyuki Kiguchi,&nbsp;Satoshi Fujimi","doi":"10.1002/ams2.70036","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Warfarin, a vitamin K antagonist, is widely used for preventing and treating thromboembolic diseases. While guidelines exist for managing elevated prothrombin time-international normalized ratio (INR) in patients on warfarin, the treatment for warfarin overdose in these patients is yet to be standardized.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>A 41-year-old woman ingested 230 mg of warfarin with suicidal intent, along with other medications. Initially unconscious, her INR was 1.0, and laboratory results were normal. Prophylactic continuous menaquinone-4, vitamin K2, injections were administered before the INR increased. After stopping vitamin K2 72 h later, her INR rose to 1.8, but she recovered without severe coagulopathy or bleeding, despite a high initial warfarin concentration.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This is the first case of warfarin overdose managed with prophylactic vitamin K2 injections before INR elevation, successfully preventing severe complications. Prophylactic vitamin K infusion may be a practical approach for warfarin overdose treatment in non-dependent patients.</p>\n </section>\n </div>","PeriodicalId":7196,"journal":{"name":"Acute Medicine & Surgery","volume":"12 1","pages":""},"PeriodicalIF":1.5000,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11712172/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acute Medicine & Surgery","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ams2.70036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Warfarin, a vitamin K antagonist, is widely used for preventing and treating thromboembolic diseases. While guidelines exist for managing elevated prothrombin time-international normalized ratio (INR) in patients on warfarin, the treatment for warfarin overdose in these patients is yet to be standardized.

Case Presentation

A 41-year-old woman ingested 230 mg of warfarin with suicidal intent, along with other medications. Initially unconscious, her INR was 1.0, and laboratory results were normal. Prophylactic continuous menaquinone-4, vitamin K2, injections were administered before the INR increased. After stopping vitamin K2 72 h later, her INR rose to 1.8, but she recovered without severe coagulopathy or bleeding, despite a high initial warfarin concentration.

Conclusion

This is the first case of warfarin overdose managed with prophylactic vitamin K2 injections before INR elevation, successfully preventing severe complications. Prophylactic vitamin K infusion may be a practical approach for warfarin overdose treatment in non-dependent patients.

Abstract Image

华法林过量成功治疗预防性维生素K输注无严重凝血功能障碍:1例报告。
背景:华法林是一种维生素K拮抗剂,广泛用于预防和治疗血栓栓塞性疾病。虽然对于华法林患者凝血酶原时间-国际标准化比值(INR)升高的管理指南已经存在,但对于这些患者华法林过量的治疗尚未标准化。病例介绍:一名41岁女性服用了230毫克华法林和其他药物,并有自杀意图。最初无意识,INR为1.0,实验室结果正常。在INR升高前预防性连续注射甲基萘醌-4、维生素K2。停用维生素K2 72小时后,她的INR上升到1.8,尽管华法林初始浓度很高,但她恢复时没有出现严重的凝血功能障碍或出血。结论:这是第一例在INR升高前预防性注射维生素K2治疗华法林过量的病例,成功预防了严重并发症。预防性维生素K输注可能是华法林非依赖患者过量治疗的一种实用方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acute Medicine & Surgery
Acute Medicine & Surgery MEDICINE, GENERAL & INTERNAL-
自引率
12.50%
发文量
87
审稿时长
53 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信